Christian Kleist
Heidelberg, BW 69120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Beyond bisphosphonates: radiolabeled phosphopeptides for bone targeting.
Journal: EJNMMI research
Published: February 11, 2026
Balancing Stealth and Targetability: cCPP- and PEG-Modified Liposomes for the Targeted Delivery of Anti-HER2 Nanobodies.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 01, 2026
Monomethyl-auristatin E-based anti-CD137 (4-1BB) antibody drug conjugates are not suitable tools to deplete activated T lymphocytes.
Journal: Immunobiology
Published: October 27, 2025
Conjugation of Polycationic Peptides Extends the Efficacy Spectrum of β-Lactam Antibiotics.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 17, 2024
Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with 213Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 10, 2024
Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrier.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: April 11, 2023
Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial.
Journal: BMJ open
Published: November 11, 2022
Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantation.
Journal: Frontiers in immunology
Published: November 04, 2022
Refined Chelator Spacer Moieties Ameliorate the Pharmacokinetics of PSMA-617.
Journal: Frontiers in chemistry
Published: March 17, 2022
Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients.
Journal: Journal of the American Society of Nephrology : JASN
Published: February 24, 2022
HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma.
Journal: Biomedicines
Published: January 12, 2022
Impact of Linker Modification and PEGylation of Vancomycin Conjugates on Structure-Activity Relationships and Pharmacokinetics.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 15, 2021
Last Updated: 09/26/2026